Tylenol and Vitreous degeneration - a phase IV clinical study of FDA data

Summary:

Vitreous degeneration is reported as a side effect among people who take Tylenol (acetaminophen), especially for people who are male, 60+ old, also take Synthroid, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Vitreous degeneration when taking Tylenol. It is created by eHealthMe based on reports of 217,809 people who have side effects when taking Tylenol from the FDA, and is updated regularly.

What is Tylenol?

Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,309 Tylenol users. Check the latest studies of Tylenol.

What is Vitreous degeneration?

Vitreous degeneration (serious vision problems in humans) is found to be associated with 35 drugs and 85 conditions by eHealthMe. Check the latest studies of Vitreous degeneration.

On Jul, 12, 2026

217,809 people reported to have side effects when taking Tylenol.
Among them, 14 people (0.01%) have Vitreous degeneration.

Could Tylenol cause Vitreous degeneration?

Among these 14 people:

What is the gender of people who have Vitreous degeneration when taking Tylenol? *

female: 20 %
male: 80 %

What is the age of people who have Vitreous degeneration when taking Tylenol? *

What are other drugs people take besides Tylenol? *

What are other side effects people have besides Vitreous degeneration? *

Joint Pain: 9 people, 64.29%
Weight Increased: 8 people, 57.14%
Abdominal Distension: 8 people, 57.14%
Fatigue (feeling of tiredness): 8 people, 57.14%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 57.14%
Back Pain: 8 people, 57.14%
Prostatic Specific Antigen Increased: 8 people, 57.14%
Chest Pain: 7 people, 50.00%
Vision Blurred: 7 people, 50.00%
Dyspnea (difficult or laboured breathing): 7 people, 50.00%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 35.71%
Constipation: 3 people, 21.43%
Hot Flush (sudden feelings of heat): 2 people, 14.29%
Gait Disturbance: 2 people, 14.29%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 14.29%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 14.29%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%
Metastases To Bone (cancer spreads to bone): 1 person, 7.14%
Joint Pain: 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tylenol and have Vitreous degeneration?

- Check whether Vitreous degeneration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tylenol:

Tylenol (222,309 reports)

Browse all side effects of Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vitreous degeneration:

Vitreous degeneration (35 drugs)

Browse all the conditions that are associated with Vitreous degeneration:

Vitreous degeneration (85 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen (the active ingredients of Tylenol) and Tylenol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.